Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
-$1,771,681 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
13 quarters on record
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$5,820,600
CallShares
356,000
PutValue
$727,575
PutShares
44,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026TUDOR INVESTMENT CORP ET AL holds $333,275,952 across 117 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
462,588 | $53,114,354 | |
| 2 | RPRX |
Royalty Pharma plc
|
671,680 | $32,220,489 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
495,591 | $28,818,616 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
650,000 | $26,149,500 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
267,520 | $14,103,654 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
900,000 | $13,014,000 | |
| 7 | ABVX |
Abivax S.A.
|
101,611 | $11,314,384 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
87,852 | $8,543,607 |
All Filings in QURE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $727,575 | 44,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $5,820,600 | 356,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $569,534 | 23,800 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $2,443,253 | 102,100 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,771,681 | 74,036 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,074,008 | 18,400 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,044,823 | 17,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $1,676,211 | 28,717 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $437,685 | 24,784 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $115,426 | 23,413 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $105,185 | 23,479 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $122,995 | 23,653 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $175,701 | 25,953 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $299,679 | 26,150 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $692,296 | 30,538 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $410,037 | 21,857 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $437,928 | 23,494 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $416,874 | 23,070 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||